nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.131	0.163	CbGbCtD
Proguanil—CYP2C19—Progesterone—uterine cancer	0.105	0.13	CbGbCtD
Proguanil—CYP1A2—Progesterone—uterine cancer	0.0967	0.12	CbGbCtD
Proguanil—CYP2C9—Progesterone—uterine cancer	0.0871	0.108	CbGbCtD
Proguanil—CYP2D6—Progesterone—uterine cancer	0.0796	0.0987	CbGbCtD
Proguanil—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0764	0.0947	CbGbCtD
Proguanil—CYP2E1—Etoposide—uterine cancer	0.0748	0.0927	CbGbCtD
Proguanil—CYP3A4—Progesterone—uterine cancer	0.0506	0.0627	CbGbCtD
Proguanil—CYP1A2—Etoposide—uterine cancer	0.0433	0.0536	CbGbCtD
Proguanil—CYP2D6—Doxorubicin—uterine cancer	0.0243	0.0301	CbGbCtD
Proguanil—CYP3A4—Etoposide—uterine cancer	0.0227	0.0281	CbGbCtD
Proguanil—CYP3A4—Doxorubicin—uterine cancer	0.0155	0.0191	CbGbCtD
Proguanil—Hepatic enzyme increased—Progesterone—uterine cancer	0.00375	0.0394	CcSEcCtD
Proguanil—Body temperature increased—Carboplatin—uterine cancer	0.00191	0.02	CcSEcCtD
Proguanil—Hepatobiliary disease—Progesterone—uterine cancer	0.00188	0.0197	CcSEcCtD
Proguanil—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.0184	CcSEcCtD
Proguanil—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.0179	CcSEcCtD
Proguanil—Immune system disorder—Progesterone—uterine cancer	0.00161	0.0169	CcSEcCtD
Proguanil—Mediastinal disorder—Progesterone—uterine cancer	0.00161	0.0169	CcSEcCtD
Proguanil—Mental disorder—Progesterone—uterine cancer	0.00156	0.0164	CcSEcCtD
Proguanil—Erythema—Progesterone—uterine cancer	0.00155	0.0163	CcSEcCtD
Proguanil—Malnutrition—Progesterone—uterine cancer	0.00155	0.0163	CcSEcCtD
Proguanil—Pancytopenia—Dactinomycin—uterine cancer	0.00149	0.0157	CcSEcCtD
Proguanil—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.0153	CcSEcCtD
Proguanil—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.0153	CcSEcCtD
Proguanil—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.0149	CcSEcCtD
Proguanil—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.0148	CcSEcCtD
Proguanil—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.0148	CcSEcCtD
Proguanil—Stomatitis—Dactinomycin—uterine cancer	0.00137	0.0144	CcSEcCtD
Proguanil—Cough—Progesterone—uterine cancer	0.00135	0.0142	CcSEcCtD
Proguanil—DHFR—myometrium—uterine cancer	0.00135	0.102	CbGeAlD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00131	0.0138	CcSEcCtD
Proguanil—Nervous system disorder—Progesterone—uterine cancer	0.00124	0.0131	CcSEcCtD
Proguanil—Skin disorder—Progesterone—uterine cancer	0.00123	0.0129	CcSEcCtD
Proguanil—Anorexia—Progesterone—uterine cancer	0.00121	0.0127	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.0125	CcSEcCtD
Proguanil—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.0118	CcSEcCtD
Proguanil—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.0117	CcSEcCtD
Proguanil—Decreased appetite—Progesterone—uterine cancer	0.0011	0.0116	CcSEcCtD
Proguanil—Erythema—Dactinomycin—uterine cancer	0.0011	0.0115	CcSEcCtD
Proguanil—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.0115	CcSEcCtD
Proguanil—Gastrointestinal disorder—Progesterone—uterine cancer	0.00109	0.0115	CcSEcCtD
Proguanil—Pancytopenia—Etoposide—uterine cancer	0.00108	0.0114	CcSEcCtD
Proguanil—DHFR—uterine cervix—uterine cancer	0.00105	0.0798	CbGeAlD
Proguanil—Gastrointestinal pain—Progesterone—uterine cancer	0.00104	0.0109	CcSEcCtD
Proguanil—Body temperature increased—Progesterone—uterine cancer	0.001	0.0105	CcSEcCtD
Proguanil—Abdominal pain—Progesterone—uterine cancer	0.001	0.0105	CcSEcCtD
Proguanil—DHFR—decidua—uterine cancer	0.000998	0.076	CbGeAlD
Proguanil—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000998	0.0105	CcSEcCtD
Proguanil—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000991	0.0104	CcSEcCtD
Proguanil—Stomatitis—Etoposide—uterine cancer	0.00099	0.0104	CcSEcCtD
Proguanil—DHFR—renal system—uterine cancer	0.00098	0.0746	CbGeAlD
Proguanil—Hepatobiliary disease—Etoposide—uterine cancer	0.000961	0.0101	CcSEcCtD
Proguanil—DHFR—endometrium—uterine cancer	0.000948	0.0721	CbGeAlD
Proguanil—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000938	0.00986	CcSEcCtD
Proguanil—DHFR—mammalian vulva—uterine cancer	0.000917	0.0698	CbGeAlD
Proguanil—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000907	0.00953	CcSEcCtD
Proguanil—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000907	0.00953	CcSEcCtD
Proguanil—DHFR—uterus—uterine cancer	0.000873	0.0665	CbGeAlD
Proguanil—Diarrhoea—Progesterone—uterine cancer	0.000866	0.00911	CcSEcCtD
Proguanil—Anorexia—Dactinomycin—uterine cancer	0.000853	0.00897	CcSEcCtD
Proguanil—Immune system disorder—Etoposide—uterine cancer	0.000824	0.00866	CcSEcCtD
Proguanil—Mediastinal disorder—Etoposide—uterine cancer	0.000822	0.00864	CcSEcCtD
Proguanil—Vomiting—Progesterone—uterine cancer	0.000805	0.00846	CcSEcCtD
Proguanil—Rash—Progesterone—uterine cancer	0.000798	0.00839	CcSEcCtD
Proguanil—Dermatitis—Progesterone—uterine cancer	0.000798	0.00838	CcSEcCtD
Proguanil—Headache—Progesterone—uterine cancer	0.000793	0.00834	CcSEcCtD
Proguanil—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000785	0.00825	CcSEcCtD
Proguanil—DHFR—female reproductive system—uterine cancer	0.000785	0.0598	CbGeAlD
Proguanil—Decreased appetite—Dactinomycin—uterine cancer	0.000778	0.00818	CcSEcCtD
Proguanil—Nausea—Progesterone—uterine cancer	0.000752	0.00791	CcSEcCtD
Proguanil—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000732	0.00769	CcSEcCtD
Proguanil—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00073	0.00767	CcSEcCtD
Proguanil—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000724	0.0076	CcSEcCtD
Proguanil—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000723	0.0076	CcSEcCtD
Proguanil—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000719	0.00756	CcSEcCtD
Proguanil—DHFR—female gonad—uterine cancer	0.000714	0.0544	CbGeAlD
Proguanil—DHFR—vagina—uterine cancer	0.00071	0.054	CbGeAlD
Proguanil—Body temperature increased—Dactinomycin—uterine cancer	0.000708	0.00744	CcSEcCtD
Proguanil—Abdominal pain—Dactinomycin—uterine cancer	0.000708	0.00744	CcSEcCtD
Proguanil—Cough—Etoposide—uterine cancer	0.000693	0.00728	CcSEcCtD
Proguanil—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000682	0.00716	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000671	0.00705	CcSEcCtD
Proguanil—Skin disorder—Etoposide—uterine cancer	0.000629	0.00661	CcSEcCtD
Proguanil—Anorexia—Etoposide—uterine cancer	0.000618	0.00649	CcSEcCtD
Proguanil—Diarrhoea—Dactinomycin—uterine cancer	0.000612	0.00644	CcSEcCtD
Proguanil—Pancytopenia—Epirubicin—uterine cancer	0.000606	0.00637	CcSEcCtD
Proguanil—Vomiting—Dactinomycin—uterine cancer	0.000569	0.00598	CcSEcCtD
Proguanil—Rash—Dactinomycin—uterine cancer	0.000564	0.00593	CcSEcCtD
Proguanil—Decreased appetite—Etoposide—uterine cancer	0.000563	0.00592	CcSEcCtD
Proguanil—Pancytopenia—Doxorubicin—uterine cancer	0.000561	0.0059	CcSEcCtD
Proguanil—Gastrointestinal disorder—Etoposide—uterine cancer	0.000559	0.00588	CcSEcCtD
Proguanil—Stomatitis—Epirubicin—uterine cancer	0.000555	0.00583	CcSEcCtD
Proguanil—Hepatobiliary disease—Epirubicin—uterine cancer	0.000538	0.00566	CcSEcCtD
Proguanil—Nausea—Dactinomycin—uterine cancer	0.000532	0.00559	CcSEcCtD
Proguanil—Gastrointestinal pain—Etoposide—uterine cancer	0.00053	0.00557	CcSEcCtD
Proguanil—Stomatitis—Doxorubicin—uterine cancer	0.000514	0.0054	CcSEcCtD
Proguanil—Body temperature increased—Etoposide—uterine cancer	0.000512	0.00538	CcSEcCtD
Proguanil—Abdominal pain—Etoposide—uterine cancer	0.000512	0.00538	CcSEcCtD
Proguanil—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000498	0.00524	CcSEcCtD
Proguanil—Immune system disorder—Epirubicin—uterine cancer	0.000462	0.00485	CcSEcCtD
Proguanil—Mediastinal disorder—Epirubicin—uterine cancer	0.000461	0.00484	CcSEcCtD
Proguanil—DHFR—lymph node—uterine cancer	0.000459	0.035	CbGeAlD
Proguanil—CYP1A2—renal system—uterine cancer	0.000455	0.0347	CbGeAlD
Proguanil—Mental disorder—Epirubicin—uterine cancer	0.000448	0.00471	CcSEcCtD
Proguanil—Erythema—Epirubicin—uterine cancer	0.000445	0.00468	CcSEcCtD
Proguanil—Malnutrition—Epirubicin—uterine cancer	0.000445	0.00468	CcSEcCtD
Proguanil—Diarrhoea—Etoposide—uterine cancer	0.000443	0.00466	CcSEcCtD
Proguanil—Immune system disorder—Doxorubicin—uterine cancer	0.000427	0.00449	CcSEcCtD
Proguanil—Mediastinal disorder—Doxorubicin—uterine cancer	0.000426	0.00448	CcSEcCtD
Proguanil—Mental disorder—Doxorubicin—uterine cancer	0.000414	0.00435	CcSEcCtD
Proguanil—Vomiting—Etoposide—uterine cancer	0.000412	0.00433	CcSEcCtD
Proguanil—Erythema—Doxorubicin—uterine cancer	0.000412	0.00433	CcSEcCtD
Proguanil—Malnutrition—Doxorubicin—uterine cancer	0.000412	0.00433	CcSEcCtD
Proguanil—CYP2E1—renal system—uterine cancer	0.00041	0.0312	CbGeAlD
Proguanil—Rash—Etoposide—uterine cancer	0.000408	0.00429	CcSEcCtD
Proguanil—Dermatitis—Etoposide—uterine cancer	0.000408	0.00429	CcSEcCtD
Proguanil—Headache—Etoposide—uterine cancer	0.000406	0.00427	CcSEcCtD
Proguanil—CYP2C19—vagina—uterine cancer	0.000404	0.0307	CbGeAlD
Proguanil—Cough—Epirubicin—uterine cancer	0.000388	0.00408	CcSEcCtD
Proguanil—Nausea—Etoposide—uterine cancer	0.000385	0.00404	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000376	0.00395	CcSEcCtD
Proguanil—Cough—Doxorubicin—uterine cancer	0.000359	0.00378	CcSEcCtD
Proguanil—Nervous system disorder—Epirubicin—uterine cancer	0.000356	0.00374	CcSEcCtD
Proguanil—Skin disorder—Epirubicin—uterine cancer	0.000353	0.00371	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000348	0.00366	CcSEcCtD
Proguanil—CYP2C9—female reproductive system—uterine cancer	0.000346	0.0264	CbGeAlD
Proguanil—Anorexia—Epirubicin—uterine cancer	0.000346	0.00364	CcSEcCtD
Proguanil—CYP3A4—renal system—uterine cancer	0.00033	0.0251	CbGeAlD
Proguanil—Nervous system disorder—Doxorubicin—uterine cancer	0.00033	0.00346	CcSEcCtD
Proguanil—CYP2E1—female reproductive system—uterine cancer	0.000328	0.025	CbGeAlD
Proguanil—Skin disorder—Doxorubicin—uterine cancer	0.000326	0.00343	CcSEcCtD
Proguanil—CYP2D6—renal system—uterine cancer	0.000324	0.0247	CbGeAlD
Proguanil—Anorexia—Doxorubicin—uterine cancer	0.00032	0.00337	CcSEcCtD
Proguanil—Decreased appetite—Epirubicin—uterine cancer	0.000316	0.00332	CcSEcCtD
Proguanil—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000314	0.00329	CcSEcCtD
Proguanil—Gastrointestinal pain—Epirubicin—uterine cancer	0.000297	0.00312	CcSEcCtD
Proguanil—Decreased appetite—Doxorubicin—uterine cancer	0.000292	0.00307	CcSEcCtD
Proguanil—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00029	0.00305	CcSEcCtD
Proguanil—Body temperature increased—Epirubicin—uterine cancer	0.000287	0.00302	CcSEcCtD
Proguanil—Abdominal pain—Epirubicin—uterine cancer	0.000287	0.00302	CcSEcCtD
Proguanil—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000275	0.00289	CcSEcCtD
Proguanil—Body temperature increased—Doxorubicin—uterine cancer	0.000266	0.00279	CcSEcCtD
Proguanil—Abdominal pain—Doxorubicin—uterine cancer	0.000266	0.00279	CcSEcCtD
Proguanil—CYP3A4—female reproductive system—uterine cancer	0.000264	0.0201	CbGeAlD
Proguanil—CYP2D6—female reproductive system—uterine cancer	0.00026	0.0198	CbGeAlD
Proguanil—DHFR—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000252	0.00298	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MLH1—uterine cancer	0.000249	0.00294	CbGpPWpGaD
Proguanil—Diarrhoea—Epirubicin—uterine cancer	0.000248	0.00261	CcSEcCtD
Proguanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000248	0.00293	CbGpPWpGaD
Proguanil—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000246	0.00291	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	0.000245	0.0029	CbGpPWpGaD
Proguanil—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000245	0.00289	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—GPX3—uterine cancer	0.000245	0.00289	CbGpPWpGaD
Proguanil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000236	0.0028	CbGpPWpGaD
Proguanil—CYP2D6—female gonad—uterine cancer	0.000236	0.018	CbGeAlD
Proguanil—DHFR—Disease—AKR1B10—uterine cancer	0.000236	0.00279	CbGpPWpGaD
Proguanil—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000233	0.00276	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000233	0.00276	CbGpPWpGaD
Proguanil—Vomiting—Epirubicin—uterine cancer	0.000231	0.00243	CcSEcCtD
Proguanil—CYP2E1—Biological oxidations—CYP11A1—uterine cancer	0.00023	0.00272	CbGpPWpGaD
Proguanil—Diarrhoea—Doxorubicin—uterine cancer	0.00023	0.00242	CcSEcCtD
Proguanil—Rash—Epirubicin—uterine cancer	0.000229	0.00241	CcSEcCtD
Proguanil—Dermatitis—Epirubicin—uterine cancer	0.000229	0.0024	CcSEcCtD
Proguanil—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	0.000228	0.0027	CbGpPWpGaD
Proguanil—Headache—Epirubicin—uterine cancer	0.000227	0.00239	CcSEcCtD
Proguanil—CYP2E1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000227	0.00268	CbGpPWpGaD
Proguanil—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000226	0.00268	CbGpPWpGaD
Proguanil—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000226	0.00267	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—YWHAE—uterine cancer	0.000225	0.00266	CbGpPWpGaD
Proguanil—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000224	0.00265	CbGpPWpGaD
Proguanil—Nausea—Epirubicin—uterine cancer	0.000216	0.00227	CcSEcCtD
Proguanil—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	0.000215	0.00254	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000214	0.00254	CbGpPWpGaD
Proguanil—Vomiting—Doxorubicin—uterine cancer	0.000214	0.00225	CcSEcCtD
Proguanil—Rash—Doxorubicin—uterine cancer	0.000212	0.00223	CcSEcCtD
Proguanil—Dermatitis—Doxorubicin—uterine cancer	0.000212	0.00222	CcSEcCtD
Proguanil—Headache—Doxorubicin—uterine cancer	0.00021	0.00221	CcSEcCtD
Proguanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000201	0.00238	CbGpPWpGaD
Proguanil—Nausea—Doxorubicin—uterine cancer	0.0002	0.0021	CcSEcCtD
Proguanil—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	0.000198	0.00234	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	0.000196	0.00232	CbGpPWpGaD
Proguanil—DHFR—Disease—RNF43—uterine cancer	0.000196	0.00232	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000195	0.00231	CbGpPWpGaD
Proguanil—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000192	0.00227	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000189	0.00224	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000189	0.00224	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	0.000189	0.00223	CbGpPWpGaD
Proguanil—DHFR—Metabolism—AKR1B1—uterine cancer	0.000184	0.00218	CbGpPWpGaD
Proguanil—DHFR—Metabolism—STAR—uterine cancer	0.000184	0.00218	CbGpPWpGaD
Proguanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000182	0.00216	CbGpPWpGaD
Proguanil—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.00018	0.00213	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	0.000178	0.0021	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000176	0.00208	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	0.000175	0.00207	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	0.000174	0.00205	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	0.000172	0.00203	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	0.000169	0.002	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CDKN2B—uterine cancer	0.000169	0.002	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	0.000167	0.00198	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000167	0.00198	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	0.000165	0.00196	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	0.000163	0.00193	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000163	0.00193	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	0.000162	0.00191	CbGpPWpGaD
Proguanil—DHFR—Disease—AKR1C1—uterine cancer	0.000161	0.00191	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	0.000161	0.00191	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	0.00016	0.00189	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000158	0.00186	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	0.000152	0.0018	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	0.000151	0.00178	CbGpPWpGaD
Proguanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000148	0.00175	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	0.000147	0.00174	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—BIRC5—uterine cancer	0.000146	0.00172	CbGpPWpGaD
Proguanil—DHFR—Metabolism—POLD1—uterine cancer	0.000144	0.00171	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000144	0.0017	CbGpPWpGaD
Proguanil—DHFR—Disease—DCN—uterine cancer	0.00014	0.00165	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	0.000138	0.00164	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	0.000136	0.00161	CbGpPWpGaD
Proguanil—DHFR—Metabolism—AKR1C1—uterine cancer	0.000135	0.0016	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000133	0.00157	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.000133	0.00157	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	0.000131	0.00155	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000129	0.00153	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	0.000129	0.00152	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	0.000129	0.00152	CbGpPWpGaD
Proguanil—DHFR—Disease—AKR1C3—uterine cancer	0.000124	0.00147	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000123	0.00145	CbGpPWpGaD
Proguanil—DHFR—Disease—HMGA1—uterine cancer	0.000121	0.00143	CbGpPWpGaD
Proguanil—DHFR—Metabolism—RRM2—uterine cancer	0.00012	0.00142	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	0.00012	0.00142	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	0.000119	0.00141	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	0.000119	0.0014	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	0.000118	0.00139	CbGpPWpGaD
Proguanil—DHFR—Metabolism—DCN—uterine cancer	0.000117	0.00138	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	0.000117	0.00138	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.000117	0.00138	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000114	0.00135	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000114	0.00135	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000113	0.00134	CbGpPWpGaD
Proguanil—DHFR—Disease—FBXW7—uterine cancer	0.000111	0.00131	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	0.00011	0.00131	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CYP11A1—uterine cancer	0.00011	0.0013	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	0.000109	0.00129	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CDKN2A—uterine cancer	0.000108	0.00128	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.000107	0.00126	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000105	0.00125	CbGpPWpGaD
Proguanil—DHFR—Metabolism—AKR1C3—uterine cancer	0.000104	0.00123	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000104	0.00123	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000104	0.00123	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	0.000102	0.0012	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	0.0001	0.00119	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	9.95e-05	0.00118	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CDKN2A—uterine cancer	9.67e-05	0.00114	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CDKN1B—uterine cancer	9.57e-05	0.00113	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	9.39e-05	0.00111	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NDUFB11—uterine cancer	9.1e-05	0.00108	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—SRD5A2—uterine cancer	9.1e-05	0.00108	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.88e-05	0.00105	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.88e-05	0.00105	CbGpPWpGaD
Proguanil—DHFR—Disease—CDKN2B—uterine cancer	8.67e-05	0.00103	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CDKN1B—uterine cancer	8.56e-05	0.00101	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—EP300—uterine cancer	8.41e-05	0.000994	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.37e-05	0.000989	CbGpPWpGaD
Proguanil—DHFR—Metabolism—STK11—uterine cancer	8.1e-05	0.000958	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CYP19A1—uterine cancer	8.1e-05	0.000958	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	7.98e-05	0.000944	CbGpPWpGaD
Proguanil—DHFR—Disease—SMAD3—uterine cancer	7.92e-05	0.000936	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	7.86e-05	0.000929	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	7.75e-05	0.000916	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	7.63e-05	0.000902	CbGpPWpGaD
Proguanil—DHFR—Disease—FGFR2—uterine cancer	7.55e-05	0.000893	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—EP300—uterine cancer	7.52e-05	0.000889	CbGpPWpGaD
Proguanil—DHFR—Disease—MTHFR—uterine cancer	7.27e-05	0.00086	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NDUFB11—uterine cancer	7.02e-05	0.00083	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SRD5A2—uterine cancer	7.02e-05	0.00083	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.82e-05	0.000806	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—STAR—uterine cancer	6.58e-05	0.000778	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—AKR1B1—uterine cancer	6.58e-05	0.000778	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.52e-05	0.000771	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SRD5A2—uterine cancer	6.46e-05	0.000764	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NDUFB11—uterine cancer	6.46e-05	0.000764	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.44e-05	0.000762	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SRD5A2—uterine cancer	6.4e-05	0.000757	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NDUFB11—uterine cancer	6.4e-05	0.000757	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.22e-05	0.000735	CbGpPWpGaD
Proguanil—DHFR—Metabolism—MTHFR—uterine cancer	6.09e-05	0.00072	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.87e-05	0.000694	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NDUFB11—uterine cancer	5.47e-05	0.000647	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SRD5A2—uterine cancer	5.47e-05	0.000647	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TP53—uterine cancer	5.38e-05	0.000636	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.31e-05	0.000628	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—POLD1—uterine cancer	5.16e-05	0.000611	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—AKR1B1—uterine cancer	5.08e-05	0.0006	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—STAR—uterine cancer	5.08e-05	0.0006	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.02e-05	0.000593	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.02e-05	0.000593	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—AKR1C1—uterine cancer	4.83e-05	0.000571	CbGpPWpGaD
Proguanil—DHFR—Disease—ERBB2—uterine cancer	4.74e-05	0.000561	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—AKR1B1—uterine cancer	4.67e-05	0.000552	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—STAR—uterine cancer	4.67e-05	0.000552	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—STAR—uterine cancer	4.63e-05	0.000547	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—AKR1B1—uterine cancer	4.63e-05	0.000547	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.58e-05	0.000541	CbGpPWpGaD
Proguanil—DHFR—Disease—CDKN1B—uterine cancer	4.39e-05	0.000519	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—RRM2—uterine cancer	4.3e-05	0.000509	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NDUFB11—uterine cancer	4.22e-05	0.000499	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SRD5A2—uterine cancer	4.22e-05	0.000499	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—DCN—uterine cancer	4.18e-05	0.000494	CbGpPWpGaD
Proguanil—DHFR—Disease—CTNNB1—uterine cancer	4.15e-05	0.000491	CbGpPWpGaD
Proguanil—DHFR—Disease—PTEN—uterine cancer	4.04e-05	0.000478	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—POLD1—uterine cancer	3.98e-05	0.000471	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKR1B1—uterine cancer	3.96e-05	0.000468	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—STAR—uterine cancer	3.96e-05	0.000468	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP11A1—uterine cancer	3.94e-05	0.000466	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.91e-05	0.000462	CbGpPWpGaD
Proguanil—DHFR—Disease—EP300—uterine cancer	3.86e-05	0.000456	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—AKR1C1—uterine cancer	3.73e-05	0.000441	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—AKR1C3—uterine cancer	3.72e-05	0.00044	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—POLD1—uterine cancer	3.66e-05	0.000433	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—POLD1—uterine cancer	3.63e-05	0.000429	CbGpPWpGaD
Proguanil—DHFR—Disease—NRAS—uterine cancer	3.61e-05	0.000427	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—AKR1C1—uterine cancer	3.43e-05	0.000405	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—AKR1C1—uterine cancer	3.4e-05	0.000402	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PTEN—uterine cancer	3.39e-05	0.0004	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—RRM2—uterine cancer	3.32e-05	0.000393	CbGpPWpGaD
Proguanil—DHFR—Metabolism—EP300—uterine cancer	3.23e-05	0.000382	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—DCN—uterine cancer	3.22e-05	0.000381	CbGpPWpGaD
Proguanil—DHFR—Disease—KRAS—uterine cancer	3.1e-05	0.000367	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—POLD1—uterine cancer	3.1e-05	0.000367	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—RRM2—uterine cancer	3.05e-05	0.000361	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—STAR—uterine cancer	3.05e-05	0.000361	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.05e-05	0.000361	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP11A1—uterine cancer	3.04e-05	0.000359	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—RRM2—uterine cancer	3.03e-05	0.000358	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—DCN—uterine cancer	2.97e-05	0.000351	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—DCN—uterine cancer	2.94e-05	0.000348	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKR1C1—uterine cancer	2.9e-05	0.000343	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—STK11—uterine cancer	2.9e-05	0.000342	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP19A1—uterine cancer	2.9e-05	0.000342	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—AKR1C3—uterine cancer	2.87e-05	0.000339	CbGpPWpGaD
Proguanil—DHFR—Disease—PIK3CA—uterine cancer	2.85e-05	0.000337	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP11A1—uterine cancer	2.79e-05	0.00033	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.77e-05	0.000327	CbGpPWpGaD
Proguanil—DHFR—Disease—HRAS—uterine cancer	2.64e-05	0.000312	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—AKR1C3—uterine cancer	2.64e-05	0.000312	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—AKR1C3—uterine cancer	2.62e-05	0.000309	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—RRM2—uterine cancer	2.59e-05	0.000306	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—DCN—uterine cancer	2.51e-05	0.000297	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—POLD1—uterine cancer	2.4e-05	0.000283	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PIK3CA—uterine cancer	2.39e-05	0.000283	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP11A1—uterine cancer	2.37e-05	0.00028	CbGpPWpGaD
Proguanil—DHFR—Disease—AKT1—uterine cancer	2.33e-05	0.000276	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.24e-05	0.000265	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKR1C3—uterine cancer	2.23e-05	0.000264	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—STK11—uterine cancer	2.23e-05	0.000264	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP19A1—uterine cancer	2.23e-05	0.000264	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—MTHFR—uterine cancer	2.18e-05	0.000257	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.1e-05	0.000248	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—STK11—uterine cancer	2.06e-05	0.000243	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP19A1—uterine cancer	2.06e-05	0.000243	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP19A1—uterine cancer	2.04e-05	0.000241	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—STK11—uterine cancer	2.04e-05	0.000241	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2e-05	0.000237	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—RRM2—uterine cancer	2e-05	0.000236	CbGpPWpGaD
Proguanil—DHFR—Metabolism—AKT1—uterine cancer	1.95e-05	0.000231	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—DCN—uterine cancer	1.94e-05	0.000229	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.91e-05	0.000226	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.83e-05	0.000216	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.82e-05	0.000216	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—STK11—uterine cancer	1.74e-05	0.000206	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.74e-05	0.000206	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.72e-05	0.000204	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—MTHFR—uterine cancer	1.68e-05	0.000199	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.63e-05	0.000193	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.56e-05	0.000184	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—MTHFR—uterine cancer	1.54e-05	0.000183	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—MTHFR—uterine cancer	1.53e-05	0.000181	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.48e-05	0.000175	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.35e-05	0.00016	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.34e-05	0.000159	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—STK11—uterine cancer	1.34e-05	0.000159	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—MTHFR—uterine cancer	1.31e-05	0.000155	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTEN—uterine cancer	1.21e-05	0.000143	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—EP300—uterine cancer	1.15e-05	0.000137	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.15e-05	0.000136	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—MTHFR—uterine cancer	1.01e-05	0.000119	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTEN—uterine cancer	9.34e-06	0.00011	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—EP300—uterine cancer	8.91e-06	0.000105	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTEN—uterine cancer	8.59e-06	0.000102	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CA—uterine cancer	8.54e-06	0.000101	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTEN—uterine cancer	8.52e-06	0.000101	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—EP300—uterine cancer	8.19e-06	9.69e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—EP300—uterine cancer	8.12e-06	9.61e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTEN—uterine cancer	7.28e-06	8.61e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—AKT1—uterine cancer	6.98e-06	8.25e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—EP300—uterine cancer	6.94e-06	8.21e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CA—uterine cancer	6.59e-06	7.79e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CA—uterine cancer	6.06e-06	7.17e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CA—uterine cancer	6.01e-06	7.11e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTEN—uterine cancer	5.62e-06	6.64e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—AKT1—uterine cancer	5.38e-06	6.37e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—EP300—uterine cancer	5.36e-06	6.33e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CA—uterine cancer	5.13e-06	6.07e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—AKT1—uterine cancer	4.95e-06	5.86e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—AKT1—uterine cancer	4.91e-06	5.8e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKT1—uterine cancer	4.19e-06	4.96e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.96e-06	4.69e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKT1—uterine cancer	3.24e-06	3.83e-05	CbGpPWpGaD
